Monopar Therapeutics
MNPR
MNPR
10 hedge funds and large institutions have $471K invested in Monopar Therapeutics in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
10
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$25.3K | |
| 2 | +$6.43K | |
| 3 | +$225 | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$24 |
Top Sellers
| 1 | -$16K | |
| 2 | -$13K | |
| 3 | -$5.32K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$742 |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$699 |